Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2018

01-02-2018 | Original Paper

Sustainability of Statewide Rapid HIV Testing in Labor and Delivery

Authors: Lynn M. Yee, Emily S. Miller, Anne Statton, Laurie D. Ayala, Sarah Deardorff Carter, Ann Borders, Amy E. Wong, Yolanda Olszewski, Mardge H. Cohen, Patricia M. Garcia

Published in: AIDS and Behavior | Issue 2/2018

Login to get access

Abstract

The objective was to assess sustainability of a statewide program of HIV rapid testing (RT) for pregnant women presenting for delivery with unknown HIV status. This is a population-based retrospective cohort study of women delivered in Illinois hospitals (2012–15). Deidentified data on RT metrics from state-mandated surveillance reports were compared using descriptive statistics and non-parametric tests of trend. Over 95% of the 608,408 women delivered had documented HIV status at presentation. The rate of undocumented HIV status rose from 4.19 to 4.75% (p < 0.001). However, overall 99.60% of women with undocumented status appropriately received RT and the proportion who did not receive RT declined (p = 0.003). The number of neonates discharged with unknown HIV status declined (p = 0.011). RT identified 23 new HIV diagnoses, representing 4.62% of maternal HIV diagnoses. In conclusion, statewide perinatal HIV RT resulted in nearly 100% of Illinois mother-infant dyads with known HIV status. Sustained RT completion represents an important prevention safety net.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Sperling R, Shapiro D, Coombs R, Todd J, Herman S, McSherry G, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996;335(22):1621–9.CrossRefPubMed
4.
Cooper E, Charurat M, Mofenson L, Hanson I, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484–94.CrossRefPubMed
5.
Townsend C, Cortina-Borja M, Peckham C, de Ruiter A, Lyall H, Tookey P. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS. 2008;22(8):973–81.CrossRefPubMed
6.
Chou R, Cantor A, Zakher B, Bougatsos C. Screening for HIV in pregnant women: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2012;157(10):719–28.CrossRefPubMed
7.
American College of Obstetricians and Gynecologists Committee on Obstetric Practice and HIV Expert Work Group. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations, Committee Opinion Number 635. Obstet Gynecol. 2015;125:1544–7.CrossRef
8.
Moyer V, U.S. Preventive Services Task Force. Screening for HIV: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;159:51–60.CrossRefPubMed
9.
Workowski K, Bolan G, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports. 2015;64(RR-03):1–137.
10.
Nesheim S, Taylor A, Lampe M, Kilmarx P, Fitz Harris L, Whitmore S, et al. A framework for elimination of perinatal transmission of HIV in the United States. Pediatrics. 2012;130(4):738–44.CrossRefPubMed
11.
12.
13.
Mahy M, Stover J, Kiragu K, Hayashi C, Akwara P, Luo C, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect. 2010;86(Suppl 2):ii48–55.PubMedPubMedCentral
14.
Whitmore S, Taylor A, Espinoza L, Shouse R, Lampe M, Nesheim S. Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics. 2012;129(1):e74–81.CrossRefPubMed
15.
Read J, Cohen R, Hance L, Machado E, Mussi-Pinhata M, Ceriotto M, et al. Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI Perinatal and LILAC cohorts. Int J Gynaecol Obstet. 2012;119(1):70–5.CrossRefPubMedPubMedCentral
16.
Liao C, Golden W, Anderson J, Coleman J. Missed opportunities for repeat HIV testing in pregnancy: implications for elimination of mother-to-child transmissions in the United States. AIDS Patient Care STDs. 2017;31(1):20–6.CrossRefPubMed
17.
Frange P, Chaix M, Veber F, Blanche S. Missed opportunities for HIV testing in pregnant women and children living in France. Pediatr Infect Dis J. 2014;33(2):e60–2.CrossRefPubMed
18.
American Academy of Pediatrics Committee on Pediatric AIDS. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics. 2008;122(5):1127–34.CrossRef
19.
Centers for Disease Control and Prevention. Achievements in Public Health: Reduction in perinatal transmission of HIV infection—United States, 1985–2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):592–7.
20.
Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women: Perinatal counseling and guidelines consultation. MMWR Morb Mortal Wkly Rep. 2001;50(RR19):59–86.
21.
Illinois Perinatal HIV Prevention Act. P.A. 93-566, amended by PA 94-0910 (2006), amended by P.L. 95-702 (2007). 2003.
22.
23.
Wong A, Garcia P, Olszewski Y, Statton A, Borders A, Grobman W, et al. Perinatal HIV testing and diagnosis in Illinois after implementation of the perinatal rapid testing initiative. Am J Obstet Gynecol. 2012;207:401.e1–6.e1.CrossRef
24.
25.
26.
27.
28.
Birkhead G, Klein S, Warren B, Candelas A, O’Connell D, Scully M, et al. Program and policy interventions for preventing mother-to-child transmission of HIV in New York State. J Public Health Manag Pract. 2010;16(6):492–504.CrossRefPubMed
29.
Levison J, Williams L, Moore A, McFarlane J, Davila J. Increasing use of rapid HIV testing in labor and delivery among women with no prenatal care: a local initiative. Matern Child Health J. 2011;15(6):822–6.CrossRefPubMed
30.
Gaur S, Whitley-Williams P, Flash C, Jimenez E, Petrova A. Disparity in hospital utilization of rapid HIV-1 testing for women in labor with undocumented HIV status. Matern Child Health J. 2010;14(2):268–73.CrossRefPubMed
31.
Burke R, Sepkowitz K, Bernstein K, Karpati A, Myers J, Tsoi B, et al. Why don’t physicians test for HIV? A review of the US literature. AIDS. 2007;21(12):1617–24.CrossRefPubMed
32.
Arya M, Patel S, Kumar D, Zheng M, Kallen M, Street R Jr, et al. Why physicians don’t ask: Interpersonal and intrapersonal barriers to HIV testing—making a case for a patient-initiated campaign. J Int Assoc Provid AIDS Care. 2016;15(4):306–12.CrossRefPubMed
33.
Dorell C, Sutton M, Oster A, Hardnett F, Thomas P, Gaul Z, et al. Missed opportunities for HIV testing in health care settings among young African American men who have sex with men: implications for the HIV epidemic. AIDS Patient Care STDs. 2011;25(11):657–64.CrossRefPubMed
34.
Mrus J, Tsevat J. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care. Med Decis Mak. 2004;24(1):30–9.CrossRef
35.
Metadata
Title
Sustainability of Statewide Rapid HIV Testing in Labor and Delivery
Authors
Lynn M. Yee
Emily S. Miller
Anne Statton
Laurie D. Ayala
Sarah Deardorff Carter
Ann Borders
Amy E. Wong
Yolanda Olszewski
Mardge H. Cohen
Patricia M. Garcia
Publication date
01-02-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1920-5

Other articles of this Issue 2/2018

AIDS and Behavior 2/2018 Go to the issue

Original Paper

Low Uptake of Voluntary Medical Male Circumcision Among High Risk Men in Malawi

Substantive Review

A Global Review of HIV Self-testing: Themes and Implications

Original Paper

Anticipated HIV Stigma and Delays in Regular HIV Testing Behaviors Among Sexually-Active Young Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women

Original Paper

Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States

Original Paper

Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial

Original Paper

Age and Age Discordance Associations with Condomless Sex Among Men Who Have Sex with Men
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits